SEC Form D · filed January 6, 2022
Eikon Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Adam M. Goulburn · Hayward, CADirectorJames M. Tananbaum · Hayward, CADirectorAlfred M. Bowie · Hayward, CAExecBenjamin M. Thorner · Hayward, CAExecDror M. Berman · Hayward, CADirectorLeon M. Chen · Hayward, CADirectorRoger M. Perlmutter · Hayward, CAExec · DirectorChris Dewey · Eden Prairie, MNExecJoe D. Davis · Southlake, TXDirectorGeorge T. Hollan · Southlake, TXDirectorTim Hauch · Eden Prairie, MNExecElaine Stageberg · Rochester, MNDirectorRaymond Updyke · New York, NYDirectorNicholas Stageberg · Rochester, MNExec · DirectorSimon J. Cox · Central, Hong KongDirectorJoshua Stone · McKinney, TXDirectorErik Antico · Fort Collins, CODirectorTrevor Woolfe · Vancouver, British Columbia, CanadaExec · DirectorManasa Mantravadi · Indianapolis, INDirectorSara Beugelmans · SAN FRANCISCO, CAExecJohn Morgan · NEW YORK, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗